Literature DB >> 27197579

Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy.

Ian Fyfe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27197579     DOI: 10.1038/nrneurol.2016.76

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Predictors of long-term disability accrual in relapse-onset multiple sclerosis.

Authors:  Vilija G Jokubaitis; Tim Spelman; Tomas Kalincik; Johannes Lorscheider; Eva Havrdova; Dana Horakova; Pierre Duquette; Marc Girard; Alexandre Prat; Guillermo Izquierdo; Pierre Grammond; Vincent Van Pesch; Eugenio Pucci; François Grand'Maison; Raymond Hupperts; Franco Granella; Patrizia Sola; Roberto Bergamaschi; Gerardo Iuliano; Daniele Spitaleri; Cavit Boz; Suzanne Hodgkinson; Javier Olascoaga; Freek Verheul; Pamela McCombe; Thor Petersen; Csilla Rozsa; Jeannette Lechner-Scott; Maria Laura Saladino; Deborah Farina; Pietro Iaffaldano; Damiano Paolicelli; Helmut Butzkueven; Alessandra Lugaresi; Maria Trojano
Journal:  Ann Neurol       Date:  2016-06-01       Impact factor: 10.422

  1 in total
  1 in total

1.  Real-Life Outcome in Multiple Sclerosis in the Czech Republic.

Authors:  Gisela Kobelt; Linus Jönsson; Miluse Pavelcova; Eva Kubala Havrdová
Journal:  Mult Scler Int       Date:  2019-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.